What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Gene
His scientific interests lie mostly in Diabetes mellitus, Internal medicine, Type 1 diabetes, Immunology and Endocrinology.
His Diabetes mellitus study incorporates themes from Insulin, Pathogenesis and Disease.
His Disease study integrates concerns from other disciplines, such as Concordance, Epigenetics, Incidence and Type 2 Diabetes Mellitus.
Paolo Pozzilli has researched Internal medicine in several fields, including Gastroenterology and Placebo.
The various areas that Paolo Pozzilli examines in his Type 1 diabetes study include Surgery, Glutamate decarboxylase, Epidemiology and Pediatrics.
As a member of one scientific family, Paolo Pozzilli mostly works in the field of Surgery, focusing on Hypoglycemia and, on occasion, Intensive care medicine and Glycated hemoglobin.
His most cited work include:
- The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry (702 citations)
- Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. (399 citations)
- Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. (386 citations)
What are the main themes of his work throughout his whole career to date?
Paolo Pozzilli spends much of his time researching Internal medicine, Diabetes mellitus, Endocrinology, Type 1 diabetes and Immunology.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Placebo.
His Diabetes mellitus research includes themes of Autoantibody, Insulin, Disease and Intensive care medicine.
His biological study spans a wide range of topics, including Surgery and Nicotinamide.
His Type 1 diabetes research is multidisciplinary, incorporating perspectives in Clinical trial, Incidence, Antigen, Pediatrics and Immunotherapy.
His Type 2 diabetes research includes themes of Obesity, Insulin resistance and Type 2 Diabetes Mellitus.
He most often published in these fields:
- Internal medicine (67.03%)
- Diabetes mellitus (71.76%)
- Endocrinology (50.27%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (67.03%)
- Diabetes mellitus (71.76%)
- Type 1 diabetes (48.38%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Diabetes mellitus, Type 1 diabetes, Type 2 diabetes and Endocrinology are his primary areas of study.
His Internal medicine research incorporates elements of Dulaglutide, Sclerostin, Placebo and Gastroenterology.
His Diabetes mellitus study combines topics from a wide range of disciplines, such as Obesity, Autoantibody, Intensive care medicine, Insulin and Disease.
His biological study spans a wide range of topics, including Clinical trial, Incidence, Metabolic control analysis, Diabetic ketoacidosis and Pediatrics.
The various areas that Paolo Pozzilli examines in his Type 2 diabetes study include Weight loss, Bioinformatics, Overweight, Quality of life and Glycemic.
His Endocrinology research includes elements of Area under the curve and Wnt signaling pathway.
Between 2017 and 2021, his most popular works were:
- Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic. (60 citations)
- Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes The TRIGR Randomized Clinical Trial (54 citations)
- Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules. (52 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Gene
The scientist’s investigation covers issues in Diabetes mellitus, Internal medicine, Type 1 diabetes, Type 2 diabetes and Obesity.
His Diabetes mellitus research is multidisciplinary, relying on both Therapeutic approach, Insulin, Pediatrics and Intensive care medicine.
Paolo Pozzilli has included themes like Autoantibody, Disease and Coronavirus disease 2019 in his Insulin study.
His study in Internal medicine is interdisciplinary in nature, drawing from both Placebo and Endocrinology.
His research in Type 1 diabetes intersects with topics in Absolute risk reduction, Randomized controlled trial, Incidence and Infant formula.
Paolo Pozzilli works mostly in the field of Type 2 diabetes, limiting it down to topics relating to Bioinformatics and, in certain cases, Osteoarthritis, Degeneration, Intervertebral disc, Stroke and Metabolic control analysis, as a part of the same area of interest.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
